Our Firm is actively filing Stryker recall lawsuits in the New Jersey multicounty litigation, and we are pleased to see that both of these proceedings are moving forward.
New York, New York (PRWEB) February 11, 2014
Hundreds of Stryker hip lawsuits (http://www.strykerhiprecallclaims.com/) filed in the wake of the 2010 recall for Rejuvenate and ABG II Modular-Neck Hip Stems continue to move forward in state and federal courts, Bernstein Liebhard LLP reports. According to court documents, a Case Management Conference has been scheduled for February 27, 2014 in the Stryker hip recall litigation currently underway in New Jersey’s Bergen County Superior Court. (In Re Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation, No. 296) The multidistrict litigation established in U.S. District Court, District of Minnesota for all federally-filed Stryker lawsuits has scheduled its next Status Conference for February 20, 2014 at 9:00 a.m. (In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, MDL No. 2441)
“Our Firm is actively filing Stryker recall lawsuits in the New Jersey multicounty litigation, and we are pleased to see that both of these proceedings are moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free legal evaluations to individuals who have suffered serious complications, allegedly related to the Stryker recall for Rejuvenate and ABG II hip stems.
Stryker Hip Recall
According to court documents, more than 20,000 Rejuvenate and ABG II hip stems had been sold worldwide prior to the announcement of the Stryker recall in July 2012. However, it is not clear how many were actually implanted in patients. Stryker pulled the metal components from the market after data indicated they were prone to fretting and corrosion at the modular-neck junction, which could cause patients to experience pain, swelling and adverse local tissue reactions. Because fretting and corrosion may still occur in the absence of symptoms, Stryker has recommended that all Rejuvenate and ABG II recipients undergo blood and imaging tests to ensure their device is functioning properly.*
Court documents indicate that more than 1,100 Stryker lawsuits alleging injuries due to the recalled Rejuvenate and ABG II component have been filed between state and federal proceedings. More than 664 are pending in the New Jersey multicounty litigation, and over 500 have been brought in the federal litigation.
According to court records, the New Jersey multicounty litigation has selected a small number of Stryker lawsuits for early mediation, and five claims have already been resolved through that process. The parties are currently preparing for the second phase of early mediation.
Alleged victims of complications related to the Stryker hip recall may be entitled to compensation for their injuries. Find out more about Stryker hip lawsuits at Bernstein Liebhard LLP’s website, or call 800-511-5092 to arrange for a free, no-obligation case review.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP